BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

433 related articles for article (PubMed ID: 15988953)

  • 1. Patient care cancer clinical trials at the National Cancer Institute: a resource for payers and providers.
    Pearson D
    Manag Care Q; 2002; 10(1):33-7. PubMed ID: 15988953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness and reimbursement in patient care.
    Antman KH; Aledort LM; Yarbro J; Wilensky G; Wojcik S; Monaco GP; Windham S
    Semin Hematol; 1989 Jul; 26(3 Suppl 3):32-45. PubMed ID: 2508228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Civilian Health and Medical Program of the Uniformed Services (CHAMPUS)/ TRICARE; coverage of phase II and phase III clinical trials sponsored by the National Institutes of Health National Cancer Institute. Final rule.
    Office of the Secretary, DoD
    Fed Regist; 2006 Jun; 71(118):35389-91. PubMed ID: 16795948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Barriers to clinical trial enrollment: are state mandates the solution?
    Hillner BE
    J Natl Cancer Inst; 2004 Jul; 96(14):1048-9. PubMed ID: 15265958
    [No Abstract]   [Full Text] [Related]  

  • 5. Medicare reimbursement for clinical trial services: understanding Medicare coverage in establishing a clinical trial budget.
    Barnes M; Korn J
    J Health Law; 2005; 38(4):609-31. PubMed ID: 16673632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Managing coverage for clinical trials.
    Newcomer LN
    Eff Clin Pract; 1999; 2(5):244-6. PubMed ID: 10623058
    [No Abstract]   [Full Text] [Related]  

  • 7. American Society of Clinical Oncology guidance statement: the cost of cancer care.
    Meropol NJ; Schrag D; Smith TJ; Mulvey TM; Langdon RM; Blum D; Ubel PA; Schnipper LE;
    J Clin Oncol; 2009 Aug; 27(23):3868-74. PubMed ID: 19581533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Civilian Health and Medical Program of the Uniformed Services (CHAMPUS); methodology for coverage of phase II and phase III clinical trials sponsored by the National Institutes of Health. Office of the Secretary; DoD. Final rule.
    Fed Regist; 2001 Jan; 66(21):8365-6. PubMed ID: 11503809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medicare's revised clinical trial policy and clinical trial-related provisions of FDAAA: what is a sponsor to do?
    Dobbins K; Scanlan K
    Food Drug Law J; 2007; 62(4):695-708. PubMed ID: 18557226
    [No Abstract]   [Full Text] [Related]  

  • 10. Five strategies for accelerating the war on cancer in an era of budget deficits.
    Doroshow JH; Croyle RT; Niederhuber JE
    Oncologist; 2009 Feb; 14(2):110-6. PubMed ID: 19147688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arizona's cancer clinical trials law: flawed process, flawed product.
    Olson-Garewal JK; Hessler K
    Hastings Cent Rep; 2001; 31(3):22-4. PubMed ID: 11478120
    [No Abstract]   [Full Text] [Related]  

  • 12. Use and coverage of novel cancer agents in managed care.
    Bailes JS
    Semin Oncol; 1994 Dec; 21(6 Suppl 14):34-7. PubMed ID: 7992098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Third party reimbursement for participation in cancer clinical trials: a proposal for legislation.
    Plaue GM
    J Contemp Health Law Policy; 2000; 16(2):305-54. PubMed ID: 10921232
    [No Abstract]   [Full Text] [Related]  

  • 14. Disparities in participation in cancer clinical trials in the United States : a symptom of a healthcare system in crisis.
    Colon-Otero G; Smallridge RC; Solberg LA; Keith TD; Woodward TA; Willis FB; Dunn AN
    Cancer; 2008 Feb; 112(3):447-54. PubMed ID: 18085590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. State payer mandates to cover care in US oncology trials: do science and ethics matter?
    Taylor PL
    J Natl Cancer Inst; 2010 Mar; 102(6):376-90. PubMed ID: 20197514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Civilian Health and Medical Program of the Uniformed Services (CHAMPUS). Office of the Secretary, DoD. Notice of expansion of cancer treatment clinical trials demonstration project.
    Fed Regist; 1999 Jun; 64(109):30490-1. PubMed ID: 10558567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Finance issue brief: continuity of care: year end report-2003.
    MacEachern L
    Issue Brief Health Policy Track Serv; 2003 Dec; ():1-25. PubMed ID: 14964235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reimbursement for cancer treatment: coverage of off-label drug indications.
    American Society of Clinical Oncology
    J Clin Oncol; 2006 Jul; 24(19):3206-8. PubMed ID: 16717290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TRICARE; coverage of National Cancer Institute (NCI) sponsored Phase I studies. Final rule.
    Office of the Secretary, DoD
    Fed Regist; 2011 Jan; 76(9):2253-4. PubMed ID: 21261129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer treatment clinical trials--DoD. Notice of demonstration project.
    Fed Regist; 1996 Jan; 61(16):1899-900. PubMed ID: 10154406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.